2024-2025

Benfenati F., Lanzani G., Papaleo F.

LIGHT4BRAIN

Hybrid biophotonic interfaces for modulating brain activity in health and disease

National

2023-2023

Papaleo F.

IBRO Meetings Support 2023

IBRO Meetings Support 2023

Others Ended

2023-2025

Stubbendorff C.

LgDel-mPFC

Social cognition in 22qll.2 schizophrenia mouse model - role of mPFC dysfunction and oxytocin

European

2022-2025

Papaleo F.

FWF Papaleo

Transporter-mediated efflux as therapeutic strategy

International

2020-2024

Papaleo F.

TELETHON 2019 Papaleo

Improving developmental trajectories in 22q11.2 deletion syndrome by oxytocin: focus on anti-inflammatory effects.

Foundation Ended

2020-2022

Papaleo F.

Research Agreement FMI - IIT

Research Agreement FMI - IIT

Others Ended

2018-2018

Scheggia D.

URBACH-ALZ

Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala

European Ended

2018-2020

Devroye C.

SOCIALBRAINCIRCUITS

Neuroanatomical substrates of social deficit in a mouse model of 22q11 deletion syndrome

European Ended

2018-2018

Papaleo F.

COST_Papaleo

Training School in Convergence Neuroscience

European Ended

2016-2018

Papaleo F.

SAN PAOLO 2015 PAPALEO

Use of genetic-driven dysbindin-1 (DTNBP1) variations for more effective and personalized healthcare in psychiatric disorders

Foundation Ended

2015-2018

Papaleo F.

NARSAD 2015 PAPALEO

Use of Genetic-driven Dysbindin-1 (DTNBP1) Variations for More Effective and Personalized Treatments in First episode of Psychosis

Foundation Ended

2010-2014

Papaleo F.

SCHIZOGENES

Role of genetic interaction between COMT and Dysbindin in cognitive and schizophrenia-related abnormalities

European Ended